Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-019"

From Bioblast
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=OXPHOS (Pal+Oct+P+G)
|abbr=Pal+Oct+P+G_OXPHOS
|description=[[File:1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-.png|450px]]
|description=[[File:1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-.png|450px]]
|info='''A:
|info='''A:

Revision as of 12:30, 5 June 2019


high-resolution terminology - matching measurements at high-resolution


SUIT-019

Description

1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-.png

Abbreviation: Pal+Oct+P+G_OXPHOS

Reference: A:

SUIT protocol pattern: 1PalM;2D;3Oct;4P;5G;6U;7S;8Rot-

SUIT-019 gives information on F-pathway in LEAK and OXPHOS states. Moreover, this SUIT protocol allows the pathway control evaluation of FN in OXPHOS state and FN, FNS and S in ET state.

Communicated by Cardoso LH, Doerrier C, Komlodi T, Gnaiger E (last update 2019-06-05)

Specific SUIT protocols

1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot;9Ama.png D045 O2 traces.png

MitoPedia: SUIT

Steps and respiratory states

1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot;9Ama.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1PalM PalML(n) F(N) CETF 1PalM
2D PalMP F(N) CETF 1PalM;2D
2c PalMP F(N) CETF 1PalM;2D;2c
3Oct PalOctMP F(N) CETF 1PalM;2D;2c;3Oct
4P PalOctPMP FN CETF&CI 1PalM;2D;2c;3Oct;4P
  • Respiratory stimulation by simultaneous action of the F-pathway and N-pathway with convergent electron flow in the FN-pathway for evaluation of an additive or inhibitory effect of F.
  • OXPHOS capacity P (with saturating [ADP]), active OXPHOS state.
5G PalOctPGMP FN CETF&CI 1PalM;2D;2c;3Oct;4P;5G
  • Respiratory stimulation by simultaneous action of the F-pathway and N-pathway with convergent electron flow in the FN-pathway for evaluation of an additive or inhibitory effect of F.
  • OXPHOS capacity P (with saturating [ADP]), active OXPHOS state.
6U PalOctPGME FN CETF&CI&II 1PalM;2D;2c;3Oct;4P;5G;6U
7S PalOctPGMSE FNS CI&CII 1PalM;2D;2c;3Oct;4P;5G;6U;7S
  • Respiratory stimulation by simultaneous action of the F-pathway, N-pathway, and S-pathway, with convergent electron flow in the FNS-pathway for reconstitution of TCA cycle function and additive or inhibitory effect of F.
  • Noncoupled electron transfer state, ET state, with ET capacity E.
8Rot SE S CII 1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot
9Ama ROX 1PalM;2D;2c;3Oct;4P;5G;6U;7S;8Rot;9Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).
Step Respiratory state Pathway control ET-Complex Comment
## AsTm AsTmE CIV CIV
## Azd CHB


Questions.jpg


Click to expand or collaps

Strengths and limitations

  • SUIT-019 allows the study of OXPHOS capacity in the fatty acid oxidation (F) and fatty acid oxidation&NADH pathway (FN) control states.
+ The protocol provides information on F-pathway (in presence of palmitoylcarnitine, and palmitoylcarnitine&octanoylcarnitine) in LEAK and OXPHOS states. In human heart muscle, the addition of octanoylcarnitine to palmitoylcarnitine&malate increased OXPHOS by 26% (Lemieux H et al 2011).
+ SUIT-019 provides information of the linear coupling (L-P) in FN-pathway.
+ Maximum ET capacity in FNS-pathway is obtained in SUIT-019.
+ P/E for FN-pathway (5G/6U) can be calculated.
+ Reasonable duration of the experiment.
- Octanoylcarnitine and palmitoylcarnitine can have an uncoupling effect on OXPHOS state if their concentration is not optimized.
- In the presence of anaplerotic pathways F-pathway is overestimated.
- CIV activity is not measured, to save experimental time.


Compare SUIT protocols

  • SUIT-002 (RP2): SUIT protocol specially designed to give information on F-pathway in OXPHOS state avoiding FAO overestimation in the presence of anaplerotic pathways. Moreover, the pathway control in OXPHOS state (F, F(N), FN, FNS, FNSGp pathways) and in ET state (FNSGp and SGp) can be evaluated by using this SUIT protocol.

References

 YearReferenceOrganismTissue;cell
Lemieux 2011 Int J Biochem Cell Biol2011Lemieux H, Semsroth S, Antretter H, Höfer D, Gnaiger E (2011) Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. https://doi.org/10.1016/j.biocel.2011.08.008HumanHeart


MitoPedia concepts: MiP concept, SUIT protocol, Recommended 


MitoPedia methods: Respirometry